Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection

References

• ChenWCancer statistics: updated cancer burden in ChinaChin J Cancer Res2015271125717219
   PubMed Web of Science ®Google Scholar
• PoonRTPrevention of recurrence after resection of hepatocellular carcinoma: a daunting challengeHepatology201154375775921793027
   PubMed Web of Science ®Google Scholar
• TralhaoJGDagherILinoTRoudieJFrancoDTreatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patientsEur J Surg Oncol200733674675117188454
   PubMed Web of Science ®Google Scholar
• McMillanDCThe systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancerCancer Treat Rev201339553454022995477
   PubMed Web of Science ®Google Scholar
• HiraokaAKumadaTMichitakaKUsefulness of albumin-bilirubin (ALBI) grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinomaJ Gastroenterol Hepatol20163151031103626647219
   PubMedGoogle Scholar
• LiuPHHsuCYHsiaCYPrognosis of hepatocellular carcinoma: Assessment of eleven staging systemsJ Hepatol201664360160826551516
   PubMed Web of Science ®Google Scholar
• SchwarzLKatzMHDiagnosis and Management of Borderline Resectable Pancreatic AdenocarcinomaHematol Oncol Clin North Am201529472774026226907
   PubMed Web of Science ®Google Scholar
• SharmaGWhangEERuanDTItoHEfficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Pancreatic Adenocarcinoma: A Decision AnalysisAnn Surg Oncol201522Suppl 3S1229S123726152276
   PubMedGoogle Scholar
• MartinRC2ndKwonDChalikondaSTreatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacyAnn Surg2015262348649426258317
   PubMed Web of Science ®Google Scholar
• LuHOuyangWHuangCInflammation, a key event in cancer developmentMol Cancer Res20064422123316603636
   PubMed Web of Science ®Google Scholar
• BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
   PubMed Web of Science ®Google Scholar
• CandidoJHagemannTCancer-related inflammationJ Clin Immunol201333Suppl 1S79S8423225204
   PubMed Web of Science ®Google Scholar
• GrivennikovSIGretenFRKarinMImmunity, inflammation, and cancerCell2010140688389920303878
   PubMed Web of Science ®Google Scholar
• LippiGMeschiTNouvenneAMattiuzziCBorghiLNeutrophil gelatinase-associated lipocalin in cancerAdv Clin Chem20146417921924938019
   PubMed Web of Science ®Google Scholar
• Del PreteAAllavenaPSantoroGFumaruloRCorsiMMMantovaniAMolecular pathways in cancer-related inflammationBiochem Med (Zagreb)201121326427522420240
   PubMed Web of Science ®Google Scholar
• HarimotoNShirabeKNakagawaraHPrognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratioTransplantation201396111008101224113512
   PubMedGoogle Scholar
• LiaoWZhangJZhuQPreoperative Neutrophil-to-Lymphocyte Ratio as a New Prognostic Marker in Hepatocellular Carcinoma after Curative ResectionTransl Oncol20147224825524704092
   PubMed Web of Science ®Google Scholar
• YangZZhangJLuYAspartate aminotransferase-lymphocyte ratio index and systemic immune-inflammation index predict overall survival in HBV-related hepatocellular carcinoma patients after transcatheter arterial chemoembolizationOncotarget2015640430904309826506519
   PubMedGoogle Scholar
• LinZXRuanDYLiYLymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resectionWorld J Gastroenterol20152138108981090626478681
   PubMedGoogle Scholar
• FanZCYanJLiuGDReal-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasisCancer Res201272102683269122454286
   PubMed Web of Science ®Google Scholar
• LiGJXuHWJiJJYangFGaoBQPrognostic value of preoperative lymphocyte-to-monocyte ratio in pancreatic adenocarcinomaOnco Targets Ther201691085109227042101
   PubMed Web of Science ®Google Scholar
• DiakosCICharlesKAMcMillanDCClarkeSJCancer-related inflammation and treatment effectivenessLancet Oncol20141511e493e50325281468
   PubMed Web of Science ®Google Scholar
• DunnGPOldLJSchreiberRDThe immunobiology of cancer immunosurveillance and immunoeditingImmunity200421213714815308095
   PubMed Web of Science ®Google Scholar
• RomanoFUggeriFCrippaSImmunodeficiency in different histotypes of radically operable gastrointestinal cancersJ Exp Clin Cancer Res200423219520015354402
   PubMed Web of Science ®Google Scholar
• von BernstorffWVossMFreichelSSystemic and local immunosuppression in pancreatic cancer patientsClin Cancer Res200173 Suppl925s932s11300493
   PubMed Web of Science ®Google Scholar
• FogarPSpertiCBassoDDecreased total lymphocyte counts in pancreatic cancer: an index of adverse outcomePancreas2006321222816340740
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• SicaAAllavenaPMantovaniACancer related inflammation: the macrophage connectionCancer Lett2008267220421518448242
   PubMed Web of Science ®Google Scholar
• TakahashiTKuniyasuYTodaMImmunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive stateInt Immunol19981012196919809885918
   PubMed Web of Science ®Google Scholar
• FidlerIJSchroitAJRecognition and destruction of neoplastic cells by activated macrophages: discrimination of altered selfBiochim Biophys Acta198894821511733052591
   PubMed Web of Science ®Google Scholar
• MytarBBaj-KrzyworzekaMMajkaMStankiewiczDZembalaMHuman monocytes both enhance and inhibit the growth of human pancreatic cancer in SCID miceAnticancer Res2008281A18719218383844
   PubMedGoogle Scholar
• BingleLBrownNJLewisCEThe role of tumour-associated macrophages in tumour progression: implications for new anticancer therapiesJ Pathol2002196325426511857487
   PubMed Web of Science ®Google Scholar
• CondeelisJPollardJWMacrophages: obligate partners for tumor cell migration, invasion, and metastasisCell2006124226326616439202
   PubMed Web of Science ®Google Scholar
• SasakiAKaiSEndoYPrognostic value of preoperative peripheral blood monocyte count in patients with colorectal liver metastasis after liver resectionJ Gastrointest Surg200711559660217468918
   PubMed Web of Science ®Google Scholar
• SasakiAIwashitaYShibataKMatsumotoTOhtaMKitanoSPrognostic value of preoperative peripheral blood monocyte count in patients with hepatocellular carcinomaSurgery2006139675576416782430
   PubMed Web of Science ®Google Scholar
• ZhangGMZhuYLuoLPreoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomyTumour Biol201536118537854326032095
   PubMedGoogle Scholar
• StotzMPichlerMAbsengerGThe preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerBr J Cancer2014110243544024357796
   PubMed Web of Science ®Google Scholar
• ZhouXDuYXuJThe preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancerTumour Biol20143511116591166625139101
   PubMedGoogle Scholar
• StarkTLivasLKyprianouNInflammation in prostate cancer progression and therapeutic targetingTransl Androl Urol20154445546326816843
   PubMedGoogle Scholar
• TomiharaKCurielTJZhangBOptimization of immunotherapy in elderly cancer patientsCrit Rev Oncog201318657358324579736
   PubMedGoogle Scholar